secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cartesian Therapeutics, Inc. (RNAC)
CIK:        0001453687
Form:       8-K
Filed at:   2023-06-16T23:59:59+00:00
Accession:  0001453687-23-000059
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Selecta Biosciences annual meeting: three directors elected; charter amendment to lower vote threshold fails
--------------------------------------------------------------------------------

- Stockholders elected Scott D. Myers, Timothy A. Springer, and Patrick Zenner as Class I directors for three-year terms.
- Advisory vote on executive compensation passed with approx. 91% of votes cast in favor (63.7M for, 5.1M against, 1.1M abstain).
- Proposal to amend certificate of incorporation to change bylaw amendment threshold from two-thirds to majority failed, receiving less than two-thirds of outstanding shares.
- Ratification of Ernst & Young as auditor for FY2023 was approved with overwhelming support.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453687/000145368723000059/0001453687-23-000059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453687/000145368723000059/selb-20230616.htm
  HTML page:      https://secwatch.observer/filing/0001453687-23-000059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer